Key Quantitative Figures

  • Authorized Share Capital: ₹9,00,00,000 (90,00,000 equity shares of ₹10 each) proposed to be increased to ₹30,00,00,000 (3,00,00,000 equity shares of ₹10 each)
  • Paid-up Equity Share Capital: ₹6,28,75,000 (63,20,000 equity shares of ₹10 each) as of March 31, 2026
  • Preferential Issue Size: Up to 2,36,48,000 convertible warrants at ₹42 per warrant, aggregating ₹99,32,16,000
  • Upfront Payment: 25% of issue price (₹10.50 per warrant) payable on allotment
  • Conversion Price: Balance 75% (₹31.50 per warrant) payable upon conversion within 18 months
  • FY 2025-26 Financials: Total Income: ₹19.92 lakh; Net Profit: ₹1.84 lakh
  • FY 2024-25 Financials: Total Income: ₹13.55 lakh; Net Profit: ₹1.58 lakh
  • Total Assets (March 31, 2026): ₹171.39 lakh
  • Total Equity (March 31, 2026): ₹150.56 lakh

Dates of Action

  • AGM Date: Sunday, October 11, 2026 at 09:30 AM
  • Record Date: Monday, October 5, 2026
  • Book Closure: October 5, 2026 to October 11, 2026 (both days inclusive)
  • E-voting Period: October 8, 2026 (9:00 AM) to October 10, 2026 (5:00 PM)
  • Preferential Issue Relevant Date: Friday, September 11, 2026 (for floor price calculation)
  • Board Meeting Dates: 8 meetings held between May 30, 2025 and March 31, 2026

Parties Involved

  • Statutory Auditors: PSV Jain & Associates, Chartered Accountants
  • Secretarial Auditors: RA Gala & Associates, Practicing Company Secretaries
  • Registrar and Share Transfer Agent: Skyline Financial Services Pvt. Ltd
  • Bankers: Allahabad Bank, Axis Bank, IDBI Bank, Kotak Bank, Punjab National Bank
  • Valuer for Preferential Issue: Bhavesh M Rathod (IBBI Reg No. IBBI/RV/06/2019/10708)
  • Scrutinizer for E-voting: Rinkesh Gala, Proprietor of Rinkesh Gala & Associates

Resolutions Proposed at AGM

Ordinary Business

1. Adoption of audited standalone financial statements for FY ended March 31, 2026

2. Re-appointment of Mr. Pareshkumar Vinodray Savani (DIN: 00103794) as director retiring by rotation

Special Business

3. Appointment of Mr. Prasham Kumar Doshi (DIN: 09567059) as Director

4. Appointment of Mr. Prasham Kumar Doshi as Managing Director for 5 years (August 19, 2026 to August 18, 2031)

5. Increase in authorized share capital from ₹9 crore to ₹30 crore

6. Preferential issue of up to 2,36,48,000 convertible warrants at ₹42 each to 23 allottees

Preferential Issue Details

Objects of the Issue

  • Healthcare and Hospital Business: ₹65 crore
  • Textile and Trading Business: ₹20 crore
  • Working Capital and Business Operations: ₹10 crore
  • General Corporate and Contingency Requirements: Balance amount

Proposed Allottees (Promoter Category)

  • Ajit Velshibhai Vasani: 7,50,000 warrants (₹3.15 crore)
  • Jagruti Ajit Vasani: 7,50,000 warrants (₹3.15 crore)

Proposed Allottees (Non-Promoter Category)

  • Gaurav Kumar Jha: 26,12,500 warrants (₹10.97 crore)
  • Agri World Ventures Private Limited: 22,50,000 warrants (₹9.45 crore)
  • Jai Shree Safe Hand Health Care Private Limited: 22,50,000 warrants (₹9.45 crore)
  • Hardik P. Deliwala: 21,12,500 warrants (₹8.87 crore)
  • 17 other allottees for the remaining warrants

Warrant Terms

  • Each warrant convertible into 1 equity share of ₹10 each at a premium of ₹32
  • 18-month conversion period from date of allotment
  • Unexercised warrants lapse after 18 months with forfeiture of upfront amount
  • Equity shares issued on conversion will rank pari-passu with existing shares

Capital Structure Impact

  • Pre-issue paid-up capital: 63,20,000 equity shares
  • Post-conversion capital: 2,99,68,000 equity shares (assuming full conversion)
  • Dilution: Significant dilution of existing shareholders' stake
  • Promoter holding change: From 0.10% to 5.03% post-issue (including promoter allottees)

Financial Impact

  • Immediate cash inflow: ₹24.83 crore (25% upfront payment on full issue)
  • Future cash inflow: ₹74.49 crore upon conversion (75% balance payment)
  • Financial impact not quantified in the disclosure for the preferential issue

Corporate Developments

  • Name Change: Company name changed from Jaihind Synthetics Ltd to Jaihind Industries Limited (approved February 5, 2026)
  • Capital Reduction: Completed reduction of issued, subscribed, and paid-up equity share capital pursuant to NCLT order dated August 1, 2025
  • Subsidiary Acquisition: Acquired 78% shareholding in Wellness & Medicial Oasisz Private Limited (CIN: U86100MR2026PTC476576) post March 31, 2026
  • Management Change: Mr. Dinesh Doshi (Whole-time Director) passed away on August 17, 2026; Mr. Prasham Kumar Doshi appointed as Additional Executive Director from August 18, 2026

Governance Updates

  • Board Composition: 6 directors (2 executive, 4 independent)
  • Board Meetings: 8 meetings held during FY 2025-26
  • Committee Meetings: Audit Committee (4 meetings), Nomination and Remuneration Committee (1 meeting), Stakeholders Relationship Committee (1 meeting)
  • Directors' Retirement: Mr. Pareshkumar Vinodray Savani retires by rotation

Auditors' Reports

  • Statutory Audit: Unmodified opinion from PSV Jain & Associates
  • Secretarial Audit: Qualified report from RA Gala & Associates noting non-appointment of internal auditor and non-uploading of policies on website
  • Cost Audit: Not applicable to the company

Other Disclosures

  • Dividend: No dividend recommended for FY 2025-26
  • CSR: Not applicable to the company
  • Internal Financial Controls: Adequate and operating effectively
  • Related Party Transactions: No material related party transactions
  • Sexual Harassment: No complaints received during FY 2025-26